also reported that MT injection reduced ibotenic acid (IBO)-induced increases in IL-1β content in AD rats, thereby protecting mitochondrial structure, improving energy metabolism, delaying neuronal apoptosis, and suppressing AD (Ni et al., 2006). The gene discussed is IL1B; the disease is Alzheimer disease.